Abstract 4997: TME profiling in Colombian men with suspected prostate cancer

Abstract Prostate cancer (PCa) features a heterogeneous tumor microenvironment (TME) that shapes evolution and therapeutic response. Although immune and stromal composition have emerged as source of prognostic biomarkers, these components remain poorly characterized in Latin American populations. No previous study has integrated computational immune deconvolution with in situ validation in this context. We aimed to define TME remodeling across malignant, adjacent, and benign prostate tissue in a Colombian cohort.RNA-seq data from 75 patients with suspected PCa were TMM-normalized and analyzed using differential expression models adjusted for PSA, age, and Gleason grade. Immune composition and stromal enrichment were inferred using CIBERSORT and xCell. For validation, six TMAs were constructed from 20 prostatectomy patients: five TMAs included three PCa-positive cases each (Gleason grades 3+3, 3+4, 4+3, 4+4, 4+5) sampling tumor and adjacent tissue, and one TMA contained benign tissue from five PCa-negative cases. IHC quantified CD8+ T-cell and CD11b+ myeloid infiltration.Deconvolution revealed distinct immune shifts between malignant and benign tissue. PCa-positive samples showed significant enrichment of M1 macrophages (p=0.02), plasmacytoid dendritic cells (p<0.001), and Th1 cells (p=0.0075), alongside elevated stromal scores (p=0.0014), indicating a predominantly inflammatory TME. In contrast, PCa-negative samples displayed higher mast cells, hematopoietic stem cells, common myeloid progenitors (all p<0.0001), NK cells (p=0.0009), CD8+ effector memory T cells (p=0.0006), and CD4+ naïve T cells (p=0.0047), consistent with an immunologically quiescent state. IHC validation confirmed increased CD8+ T-cell infiltration in tumor versus adjacent (p<0.001) and benign tissue (p=0.016), and higher CD11b+ myeloid infiltration versus adjacent (p=0.002) and benign tissue (p=0.040). Critically, CD11b+ infiltration correlated with Gleason grade, while CD8+ infiltration remained elevated across all grades.This study provides the first multimodal TME profiling in a Colombian PCa cohort. Integration of RNA-seq deconvolution with TMA-based IHC reveals immune remodeling characterized by enrichment of cytotoxic T cells and myeloid populations in malignant tissue. The grade-dependent CD11b+ infiltration suggests potential as a stratification biomarker for immunotherapy and supports therapeutic targeting of myeloid cells in underrepresented populations. Citation Format: Dayanne M. Rodríguez Hernández, Jovanny Zabaleta, Luis D Valle, Rafael Parra-Medina, Carmen L. Roa, Alvaro Gutierrez, Mateo Barros Barraza, Alba Lucía Cómbita. TME profiling in Colombian men with suspected prostate cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4997.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-4997
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4997: TME profiling in Colombian men with suspected prostate cancer

Jovanny Zabaleta, Carmen Lucía Roa, Alba Lucía Cómbita, Mateo Barros Barraza et al.
Cancer Research
Cancer Immunotherapy and Biomarkers
article

Abstract 4997: TME profiling in Colombian men with suspected prostate cancer

Jovanny Zabaleta, Carmen Lucía Roa, Alba Lucía Cómbita, Mateo Barros Barraza, Alvaro Gutierrez, Luis D Valle, Rafael Parra-Medina
article en

Abstract

Abstract Prostate cancer (PCa) features a heterogeneous tumor microenvironment (TME) that shapes evolution and therapeutic response. Although immune and stromal composition have emerged as source of prognostic biomarkers, these components remain poorly characterized in Latin American populations. No previous study has integrated computational immune deconvolution with in situ validation in this context. We aimed to define TME remodeling across malignant, adjacent, and benign prostate tissue in a Colombian cohort.RNA-seq data from 75 patients with suspected PCa were TMM-normalized and analyzed using differential expression models adjusted for PSA, age, and Gleason grade. Immune composition and stromal enrichment were inferred using CIBERSORT and xCell. For validation, six TMAs were constructed from 20 prostatectomy patients: five TMAs included three PCa-positive cases each (Gleason grades 3+3, 3+4, 4+3, 4+4, 4+5) sampling tumor and adjacent tissue, and one TMA contained benign tissue from five PCa-negative cases. IHC quantified CD8+ T-cell and CD11b+ myeloid infiltration.Deconvolution revealed distinct immune shifts between malignant and benign tissue. PCa-positive samples showed significant enrichment of M1 macrophages (p=0.02), plasmacytoid dendritic cells (p<0.001), and Th1 cells (p=0.0075), alongside elevated stromal scores (p=0.0014), indicating a predominantly inflammatory TME. In contrast, PCa-negative samples displayed higher mast cells, hematopoietic stem cells, common myeloid progenitors (all p<0.0001), NK cells (p=0.0009), CD8+ effector memory T cells (p=0.0006), and CD4+ naïve T cells (p=0.0047), consistent with an immunologically quiescent state. IHC validation confirmed increased CD8+ T-cell infiltration in tumor versus adjacent (p<0.001) and benign tissue (p=0.016), and higher CD11b+ myeloid infiltration versus adjacent (p=0.002) and benign tissue (p=0.040). Critically, CD11b+ infiltration correlated with Gleason grade, while CD8+ infiltration remained elevated across all grades.This study provides the first multimodal TME profiling in a Colombian PCa cohort. Integration of RNA-seq deconvolution with TMA-based IHC reveals immune remodeling characterized by enrichment of cytotoxic T cells and myeloid populations in malignant tissue. The grade-dependent CD11b+ infiltration suggests potential as a stratification biomarker for immunotherapy and supports therapeutic targeting of myeloid cells in underrepresented populations. Citation Format: Dayanne M. Rodríguez Hernández, Jovanny Zabaleta, Luis D Valle, Rafael Parra-Medina, Carmen L. Roa, Alvaro Gutierrez, Mateo Barros Barraza, Alba Lucía Cómbita. TME profiling in Colombian men with suspected prostate cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4997.

Cancer ResearchVol. 86(7_Supplement)
University of New Orleans (US), Instituto Nacional de Cancerología (CO), Louisiana State University Health Sciences Center New Orleans (US)
Good health and well-being
Openalex Percentile: Top 22%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.